Not that I want to get bogged down in this discussion as it is an NCYT thread. The UK is actually 28th worst in the world for infection rate, however again if you take the amount of testing conducted here is far higher again our stats are skewed unfavourably in the world. If everyone did the same amount of tests per pop you can bet that the UK's infection rates would seem far more favourable. As to Germany I would agree they had a better program, but they are a rare exception. Efficient little devils that they are ;)
I see a lot of people keep knocking the UK here as they don't often apply critical thinking and just swallow the spoon fed MSM narrative. The UK is 3rd in the world at doing the most cv19 tests behind only USA and Russia. UK has done nearly 9m tests, France which people keep harping on about on NCYT have managed only 1.3m tests, Germany who everyone thinks is doing brilliantly have done 5.5m. If you look at it per 1m people, and discount countries with populations less than 10m the UK is top averaging 125k/1m people. This is way ahead of other Western countries. This will explain a lot of why the UK has such high numbers of cases - the more you test the more you find. As to deaths, their are macro/economic/social factors there, but also the biggest thing is the way deaths are measured. For example in the UK every death is tested for cv19, in Germany if you die of a heart attack, they don't test for CV19. This completely skews the figures.
I think people don't fully yet grasp the potential of Exsig Direct. They have basically created a very easy dna extraction tool, that removes the need for all the reagents. Shortage in reagents gone, prep time reduced, cheaper to produce and higher throughput. Now what everyone has missed this is that this can be used in any PCR open test in the world. ANY. Think of thermofisher, Roche, Abbot, they could all utilise this extraction step in their own PCR tests. I'd imagine they'd all want this extraction step in their tests. The market just got a whole lot bigger.
ShaunP - that's rubbish im afraid. Shorting aim stocks is one of the most highly lucrative businesses in the world. Why because its so volatile. Jo Public might not short so much, but you bet the big boys do. Let me give you an example, brokers for your aim shares are often the most corrupt in the world, the way they make the most money they can is by placing. They actively encourage companies they are affiliated to, to place. I suspect they will even force it on a company to place more shares than it needs by keeping the price low. Its an old boys club, mm's and brokers know each over very well and word spreads so they know the tail is wagging the dog, often a stock will be driven up before a placing and shorts will be placed. Its an easy system, sometimes a company like NCYT comes along that doesn't need and refuses a placing. Brokers jobs are reliant on being able to make the big trades for the big companies at the price they want if they can't fulfil that order they have a great chance of losing that client. NCYT refuses to offer a placing to the broker, the brokers clients become upset, it wants to buy in cheap, so a shorting attack comes with fake id's. When people are naïve enough to say a BB can't influence a SP and that narrative is backed by actual shorters. Wake up. As investors you can learn and play the game or hold strong.
RE: Considering regulatory pressure, any French speakers,12 Jun 2020 13:56
CocoCola - I doubt much will get done, but yep it is fishy alright. It all seemed to start happening not long after Graham said he'd had lots of II interest (i.e the brokers begging him to do a placing and let them in), but he refused as they didn't need the cash - and suddenly despite continuous great news the SP keeps falling. Unfortunately AIM is awash with this sort of behaviour, the FCA will do feck all about it.
Ed - TF bought out Quiagen, just after they posted a quarter loss of 160m, the SP was nearly double by the time the deal was concluded even though Quiagen had 1.5b in debt. Now in times like this, a debt free company, printing great profits, I've seen companies snapped up for 2-4x current sp.
Bramley - I was pondering that exact same thing. Mm's always do it for their mates. Just would love NCYT to do one of their Friday PM RNS's to screw em over. However if I was a betting man I'd expect news to be next week now, hopefully get the US OEM news and Exsig launch.
RE: Gov Webinar innovations on testing10 Jun 2020 14:00
Captn - they also said they hope to have Saliva to add to the other tests of PCR/POC and Antibody - it is due to be ready in Autumn but significant hurdles to overcome yet - and also its being developed by Lighthouse Labs - not AVCT...Oh dear.
Latest government/industry webinar is taking place today 13:00! The webinar will give an update on the COVID-19 National #Testing Programme, focusing on #innovation in testing. Speakers include @JimBethell and BIA's CEO Steve Bates.